College of Pharmacy researcher investigating COVID-19 vaccine

807
Martin D'Souza in his lab

Mercer University College of Pharmacy faculty member Martin D’Souza, Ph.D., recently began research into designing a microparticle vaccine for COVID-19.

Dr. D’Souza has previously used patented nanotechnology to design and deliver nanovaccines for infectious diseases and cancer. His approach involves using tiny “bead-like” nanoparticles and microparticles to deliver drugs and vaccines.

“The advantage of putting a vaccine in a microparticle is that it looks even more foreign to the body,” said Dr. D’Souza. “Therefore, the body creates an even stronger immune response.”

Continue reading about D’Souza’s work on a COVID-19 vaccine at news.mercer.edu.

 

Do you have a story idea or viewpoint you'd like to share with The Den?
Get in touch with us by emailing den@mercer.edu or submitting this online form.
Kyle is senior director of media relations at Mercer. In addition to being the primary media contact for most academic and administrative units of the university, he serves as editor of the Mercerian alumni magazine and News@Mercer e-newsletters, and he coordinates hometown and university news releases.